7.3 Quality Control & CLIA-Waived POC Testing
Key Takeaways
- Run and document quality control (QC) successfully before reporting patient results on CLIA-waived and other POC devices—failed QC means stop patient testing.
- Hematology POC may include hematocrit, hemoglobin, ESR, and coagulation (e.g., PT/INR) with method-specific sample requirements and reference ranges.
- Chemistry waived tests commonly include glucose, PKU screening collections, and kidney/liver-related assays per kit; follow timing, fasting, and sample-type rules.
- Immunoassay POC (rapid flu, strep) and fecal occult blood (hemoccult/FIT per kit) require correct swabbing, timing windows, and internal control line interpretation.
- Urine dipstick and urine hCG are high-volume waived tests—know timing, first-morning preference for hCG when possible, and that QC and expiration dating still apply.
CLIA-Waived Testing and Why QC Comes First
CLIA (Clinical Laboratory Improvement Amendments) regulates laboratory testing. Waived tests are simple methods with low risk of erroneous results when manufacturers’ directions are followed exactly—but “waived” does not mean unregulated or optional. Task 3.03.19 (quality control) and 3.03.20 (perform CLIA-waived tests) sit together because no patient result is trustworthy without passing QC and correct technique.
Ambulatory CMACs run large volumes of glucose, urine dipsticks, rapid strep/flu, hCG, occult blood, hemoglobin/hematocrit, and sometimes INR. Each wrong result can change medications, antibiotics, or pregnancy counseling.
3.03.19 Quality Control Before Testing
What QC is
Quality control uses materials with known expected ranges (liquid controls, electronic simulators, internal kit controls) to prove the reagent + device + operator process works that day.
| QC concept | Meaning |
|---|---|
| Internal control | Built into many cassettes (control line must appear) |
| External control | Separate positive/negative or multilevel liquids run on a schedule |
| Electronic QC / simulator | Device self-check or coded chip per manufacturer |
| Calibration / code chip | Matches reagent lot to meter—do not ignore prompts |
| Lot / expiration | Expired strips or kits fail compliance even if “they still work” |
| Frequency | New kit lot, new shipment, scheduled daily/weekly, after troubleshooting—follow package insert and office policy |
Non-negotiable QC rules
- Run QC when required before patient testing for that shift/lot/device.
- Document date, time, lot numbers, results, pass/fail, operator initials.
- If QC is out of range: do not test or report patients. Repeat QC per insert; change reagents; troubleshoot device; escalate to lab lead/provider. Document corrective action.
- Never “average” a fail with a pass or invent control values.
- Store controls and kits at required temperature; do not use kits left in a hot car.
- Patient testing after failed QC is a critical quality and legal failure.
Pre-analytical QC mindset (not only bottles of control)
QC also fails when the sample is wrong: wet alcohol on fingerstick glucose, expired dipstick bottle left open, wrong swab for flu, reading a strep cassette after the maximum time (false positives from evaporation lines). Operator competence is part of quality.
3.03.20 CLIA-Waived POC Categories
Hematology-related POC
| Test | Sample / notes | Exam points |
|---|---|---|
| Hemoglobin (Hgb) | Capillary or venous per device | Match cuvette/lot; no air bubbles in microcuvette; results in g/dL |
| Hematocrit (Hct) | Spun microhematocrit or calculated/device method | Proper fill and sealing of capillary tube if spun; safety on centrifuge |
| ESR (erythrocyte sedimentation rate) | Whole blood, often EDTA; timed vertical tube methods | Mix well; correct tube; exact timing; temperature effects |
| Coagulation (PT/INR) | Fresh fingerstick or citrated venous per meter | Critical for warfarin monitoring; correct sample type; strip codes; critical values notify provider immediately |
INR critical action: know clinic panic thresholds and who to call—do not only file a number.
Chemistry-related POC
| Test | Clinical use | Collection tips |
|---|---|---|
| Glucose | Diabetes screen/monitor | Wipe first drop; dry site; correct strip lot; distinguish fasting vs random when documenting |
| PKU / newborn metabolic screening | State program filter paper | Heel stick; fully saturated circles; air dry; incomplete spots invalid |
| Kidney-related (e.g., creatinine, eGFR tools, urine albumin per kit) | CKD screening/monitoring | Method-specific sample (blood vs urine); interfering substances per insert |
| Liver-related (e.g., some waived ALT or multi-chemistry cartridges where available) | Hepatic screening | Follow cartridge warm-up and sample volume exactly |
Not every clinic offers the same waived menu—exam stems still expect you to know glucose technique, newborn screen spot quality, and that chemistry cartridges are not interchangeable across brands.
Fecal occult blood (Hemoccult / guaiac vs FIT)
| Method | Principle | Patient factors |
|---|---|---|
| Guaiac (gFOBT) | Peroxidase activity of heme | Dietary restrictions often apply (red meat, some veggies, vitamin C)—follow kit; develop cards with developer at correct time |
| FIT (fecal immunochemical) | Antibodies to human hemoglobin | Usually fewer diet restrictions; use correct tube and brush |
MA role: instruct collection, check expiration, apply developer correctly, read within time window, document, route positives for follow-up colonoscopy pathways per provider. Do not call guaiac results without developing if the card requires developer.
Immunoassay rapid tests
| Test | Specimen | Critical technique |
|---|---|---|
| Rapid influenza | Nasal or NP per kit | Correct swab type/depth; extract in reagent; exact drops; read time window |
| Rapid strep A | Throat swab | Tonsillar pillars/pharynx; avoid tongue; internal control line must show |
| Other antigen/Ab kits (RSV, COVID, mono, etc., when waived) | Per insert | Never swap buffers between brands |
Interpreting cassettes:
- Control line absent → invalid—repeat with new kit, do not report.
- Control present + test line → positive (per kit definition).
- Control present, no test line → negative.
- Reading too early → false negative risk; too late → false positive from evaporation.
Urinalysis dipstick and urine hCG
Dipstick (UA reagent strip):
- Use fresh well-mixed urine; note if refrigerated specimen was returned to room temp per policy.
- Briefly dip all pads; blot edge; keep strip horizontal.
- Read each pad at manufacturer-specified seconds—leukocytes, nitrite, protein, blood, glucose, ketones, bilirubin, urobilinogen, pH, specific gravity have different timings on many brands.
- Compare to bottle color chart under good light—not under tinted glasses only.
- Cap bottle immediately; protect strips from humidity.
| Pad (examples) | Clinical clue |
|---|---|
| Leukocyte esterase / nitrite | Possible UTI (not definitive alone) |
| Blood | Hematuria, hemoglobinuria, myoglobin—correlate clinically |
| Protein | Kidney disease, contamination, etc. |
| Glucose / ketones | Diabetes, DKA risk context |
| Specific gravity / pH | Concentration and acid-base clues |
Urine hCG (pregnancy):
- Prefer first-morning urine for early pregnancy (higher hCG concentration).
- Follow cassette timing; invalid without control line.
- Document LMP if protocol asks; report promptly—false negatives possible early or with dilute urine.
- Positive results need clinical correlation and provider follow-up instructions; know clinic policy for confidential adolescent care.
Integrated POC Workflow
- Verify order and patient ID.
- Confirm kit not expired; correct storage.
- Confirm QC status current and passed; run QC if due.
- Collect proper specimen (capillary rules from Ch. 6; swabs/urine from 7.1–7.2).
- Perform test exactly per insert.
- Interpret including internal controls.
- Document result, units, method, lot if required, operator, critical callbacks.
- Clean device per manufacturer; dispose of biohazard waste.
chartType: bar
data: [{"name":"QC pass","value":1},{"name":"Collect","value":2},{"name":"Run test","value":3},{"name":"Read controls","value":4},{"name":"Document","value":5}]
title: Waived POC Safe Sequence (Logical Steps)
Critical Values and Communication
POC does not end at the number. Examples requiring immediate provider notification (thresholds are facility-specific):
- Very high/low glucose
- Critical INR
- Unexpected positive hCG in certain clinical contexts
- Markedly abnormal Hgb
Read-back phone results when policy requires. Document who was told and when.
Common CMAC Traps for Waived Testing
| Trap | Why wrong |
|---|---|
| Skipping QC because “busy clinic” | Regulatory and safety breach |
| Using expired strips | Invalid results |
| Reading strep cassette next morning | Outside read window |
| First drop of fingerstick glucose kept | Tissue fluid/alcohol error |
| Dipstick read all pads at 2 minutes regardless of insert | Wrong timing per analyte |
| Reporting invalid kit (no control line) as negative | Invalid ≠ negative |
| Mixing Brand A buffer with Brand B cassette | Not interchangeable |
Linking to Other Blueprint Tasks
- Capillary technique (3.03.13) feeds glucose/Hgb.
- Urine collection (3.03.14–15) feeds dipstick/hCG.
- Swab technique (3.03.16) feeds strep/flu.
- Labeling/documentation (3.03.17–18) apply to POC cassettes and log books.
- Law/ethics domain: CLIA certificate, scope, and truthful result reporting.
Bottom line for exam day: if the stem says QC failed, the answer is stop patient testing and troubleshoot—never “run the patient anyway and note QC later.” If the stem is a waived kit, the answer almost always includes follow manufacturer timing, controls, and sample type exactly.
External liquid QC on the office glucose meter is outside the acceptable range after a valid repeat. What should the medical assistant do?
A rapid strep cassette shows no control line and a faint test line at the correct read time. How should this be interpreted?
Which practice is correct when performing a urine reagent-strip (dipstick) test?
Why is first-morning urine often preferred for urine hCG pregnancy testing?